Contact - ACME-POCT
Contact
|
Wilbur A. Lam, MD, PhD |
Wilbur A. Lam, MD, PhD is a physician-scientist-engineer trained in clinical pediatric hematology/oncology as well as bioengineering with appointments at Georgia Tech, Emory University School of Medicine and Children’s Healthcare of Atlanta. He has specific research experience in micro/nanosystems and microfluidic technologies and has unique experience in advancing biomedical research with a specific focus on the cellular mechanics of hematologic processes and diseases. Dr. Lam’s group is also dedicated toward translating technologies from bench to bedside as novel diagnostics and therapeutics. To date, he was co-founded 3 startup companies (2 focused on POC diagnostics and 1 focused on targeted drug delivery systems). Recently, one of the companies received FDA 510(k) clearance for a color-based, disposable POC anemia diagnostic device. With his clinical, scientific and engineering background and expertise in medical innovation, he will assist project teams in the overall strategy for their POC technologies, refinement of their technologies, identification of clinical/translational needs, and execution of project milestones. |
|
|
|
|
Greg Martin, MD, MSc |
Greg Martin, MD, MSc is professor of medicine and executive associate division director for the Emory University School of Medicine Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, and is the section chief and director of medical and coronary intensive care at Grady Memorial Hospital. He serves as the director of the Emory/Georgia Tech Predictive Health Institute and the affiliated Center for Health Discovery and Well Being that presaged the currently funded Precision Medicine (All of Us) initiative. Greg also leads the Clinical Research Centers for the Georgia CTSA, where he is responsible for all aspects of research projects and staff in the statewide distributed research network. Greg has extensive expertise in clinical and translational human subjects research and hemodynamic and cardiopulmonary monitoring. Given his successful track record of clinical and translational leadership, he will lend his expertise in didactic and practical aspects of clinical research, validation, clinical needs assessment, epidemiology and biostatistics to ACME-POCT funded projects. |
|
Erika Tyburski |
Erika Tyburski is the Director of Operations of ACME-POCT. She is a biomedical engineer and entrepreneur with over 7 years of industry experience bridging the gap between academic project research and translation into the market. Erika co-founded her own point-of-care diagnostics company in 2014 and as CEO, led a point-of-care device through the phases of ideation, development and translation including: completion of clinical testing, design control, company formation, license negotiation, FDA compilation, submission and clearance, quality management systems and launch into market. She will interface with project teams on a day-to-day basis, continually advising and assessing project teams for clinical, regulatory, user needs, and business/commercialization strategies to ensure project progress. She also manages ACME-POCT logistics including coordination of regular meetings, annual pilot competitions, monthly Executive Committee Meetings, and the annual External Advisory Board meeting. |
